These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3012935

  • 1. Neutrophil aggregation--factors modulating stimulus-specific responses.
    Ringertz B.
    Acta Pathol Microbiol Immunol Scand C; 1986 Feb; 94(1):1-9. PubMed ID: 3012935
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation.
    Beckman JK, Gay JC, Brash AR, Lukens JN, Oates JA.
    Lipids; 1985 Jun; 20(6):357-60. PubMed ID: 2991693
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
    Rossi AG, MacIntyre DE, Jones CJ, McMillan RM.
    J Leukoc Biol; 1993 Feb; 53(2):117-25. PubMed ID: 8383164
    [Abstract] [Full Text] [Related]

  • 4. Stimulus-specific neutrophil aggregation: evaluation of possible mechanisms for the stimulus-response apparatus.
    Ringertz B, Palmblad J, Lindgren JA.
    J Lab Clin Med; 1985 Aug; 106(2):132-40. PubMed ID: 2991400
    [Abstract] [Full Text] [Related]

  • 5. Leukotriene B4 triggers highly characteristic and specific functional responses in neutrophils: studies of stimulus specific mechanisms.
    Palmblad J, Gyllenhammar H, Ringertz B, Nilsson E, Cottell B.
    Biochim Biophys Acta; 1988 Aug 19; 971(1):92-102. PubMed ID: 2457394
    [Abstract] [Full Text] [Related]

  • 6. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
    Jackson WT, Boyd RJ, Froelich LL, Mallett BE, Gapinski DM.
    J Pharmacol Exp Ther; 1992 Dec 19; 263(3):1009-14. PubMed ID: 1335049
    [Abstract] [Full Text] [Related]

  • 7. Agonist-induced calcium flux, phosphoinositide metabolism, aggregation and enzyme secretion in human neutrophils.
    Rossi AG, McMillan RM, MacIntyre DE.
    Agents Actions; 1988 Jul 19; 24(3-4):272-82. PubMed ID: 2845744
    [Abstract] [Full Text] [Related]

  • 8. Generation of leukotrienes by human monocytes pretreated with cytochalasin B and stimulated with formyl-methionyl-leucyl-phenylalanine.
    Williams JD, Robin JL, Lewis RA, Lee TH, Austen KF.
    J Immunol; 1986 Jan 19; 136(2):642-8. PubMed ID: 3001181
    [Abstract] [Full Text] [Related]

  • 9. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP.
    J Immunol; 1986 Jun 01; 136(11):4213-9. PubMed ID: 3009618
    [Abstract] [Full Text] [Related]

  • 10. Human monocyte and polymorphonuclear leukocyte chemotactic and chemokinetic responses to leukotriene B4 and FMLP.
    Ternowitz T, Herlin T, Fogh K.
    Acta Pathol Microbiol Immunol Scand C; 1987 Apr 01; 95(2):47-54. PubMed ID: 3037849
    [Abstract] [Full Text] [Related]

  • 11. Regulation of human neutrophil aggregation: comparable latent times, activator sensitivities, and exponential decay in aggregability for FMLP, platelet-activating factor, and leukotriene B4.
    Rochon YP, Frojmovic MM.
    Blood; 1993 Dec 01; 82(11):3460-8. PubMed ID: 8241512
    [Abstract] [Full Text] [Related]

  • 12. Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation.
    Zhou W, Javors MA, Olson MS.
    Arch Biochem Biophys; 1994 Feb 01; 308(2):439-45. PubMed ID: 8109973
    [Abstract] [Full Text] [Related]

  • 13. Role of resident mast cells and macrophages in the neutrophil migration induced by LTB4, fMLP and C5a des arg.
    Ribeiro RA, Souza-Filho MV, Souza MH, Oliveira SH, Costa CH, Cunha FQ, Ferreira HS.
    Int Arch Allergy Immunol; 1997 Jan 01; 112(1):27-35. PubMed ID: 8980461
    [Abstract] [Full Text] [Related]

  • 14. Granulocyte-macrophage colony stimulating factor potentiates human polymorphonuclear leukocyte aggregation responses to formyl-methionyl-leucyl-phenylalanine.
    Conti P, Reale M, Barbacane RC, Panara MR, Bongrazio M, Fiore S, Mier JW, Dempsey RA.
    Immunol Lett; 1992 Mar 01; 32(1):71-9. PubMed ID: 1323527
    [Abstract] [Full Text] [Related]

  • 15. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.
    Del Maschio A, Evangelista V, Rajtar G, Chen ZM, Cerletti C, De Gaetano G.
    Am J Physiol; 1990 Mar 01; 258(3 Pt 2):H870-9. PubMed ID: 2156456
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites.
    Haines KA, Giedd KN, Rich AM, Korchak HM, Weissmann G.
    Biochem J; 1987 Jan 01; 241(1):55-62. PubMed ID: 3032161
    [Abstract] [Full Text] [Related]

  • 20. Mepacrine inhibits fMLP-induced activation of human neutrophil granulocytes, leukotriene B4 formation, and fMLP binding.
    Földes-Filep E, Filep JG.
    J Leukoc Biol; 1992 Nov 01; 52(5):545-50. PubMed ID: 1331280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.